Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals, 43665-43666 [2021-17045]
Download as PDF
<![CDATA[
43665
Federal Register / Vol. 86, No. 151 / Tuesday, August 10, 2021 / Notices
Response: Thank you for your
comment. The new ICEEA law does
allow for the development of existing
Native CDFIs. Therefore, should a
Native CDFI submit an application that
proposes a project for any of the
following projects: (1) The development
of a tribal code or courts system for
purposes of economic development,
including commercial codes, training
for court personnel, (2) the development
of non-profit subsidiaries or other tribal
business structures; or ‘‘(3) the
development of a tribal master plan for
community and economic development
and infrastructure’’ and the application
includes the economic priority area(s) in
the project goal, all objectives and
indicators as reflected in the project’s
framework, project approach, OWP, and
outcome tracker, they will be awarded
points. ANA will instruct reviewers to
provide all bonus points for
applications that propose an economic
priority project that expands or creates
a Native CDFI.
Elizabeth Leo,
Senior Grants Policy Specialist, Office of
Grants Policy, Administration for Children
and Families.
[FR Doc. 2021–16959 Filed 8–9–21; 8:45 am]
BILLING CODE 4184–34–P
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review; Survey
of the National Survey of Child and
Adolescent Well-Being (NSCAW)
Adopted Youth, Young Adults, and
Adoptive Parents (0970–0555)
Office of Planning, Research,
and Evaluation, Administration for
Children and Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF) at the U.S.
Department of Health and Human
Services (HHS) seeks approval for an
extension with no changes to a one-time
study to examine familial outcomes 8
years or more after a child’s adoption
from the child welfare system. The
primary objective of this study is to
estimate the prevalence of instability
events that occur in families who have
adopted children who have exited the
foster care system. The second objective
is to understand risk and protective
factors associated with post adoption
instability. Office of Management and
Budget (OMB) approval expires
September 30, 2021, and this request is
to extend approval to allow for the
completion of data collection.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION:
Description: Through this study, ACF
is conducting web or telephone surveys
with adopted youth, young adults, and
adults as well as adoptive parents who
were participants in the first or second
cohort of NSCAW (NSCAW I, II; OMB
#0970–0202). The surveys are designed
to collect information about instability
events (such as foster care re-entry or
running away that occurred after a
child’s adoption) as well as family
functioning, perceptions of the adoption
relationship, and services and support
received after adoption. Due to the
COVID–19 pandemic, initial activities to
contact potential respondents were
delayed. As a result, ACF is requesting
an extension to collect data beyond the
current OMB expiration date of
September 30, 2021.
Respondents: Adopted youth, young
adults, adults, and their associated
adoptive parents who participated in
NSCAW I or II.
ADDRESSES:
ANNUAL BURDEN ESTIMATES
Number of
respondents
(total over
request
period)
Instrument
Survey of NSCAW Adopted Youth, Young Adults, and
Adults ................................................................................
Survey of NSCAW Adoptive Parents ..................................
jbell on DSKJLSW7X2PROD with NOTICES
Estimated Total Annual Burden
Hours: 571.
Authority: Child Abuse Prevention
and Treatment and Adoption Reform
Act of 1978.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2021–16979 Filed 8–9–21; 8:45 am]
BILLING CODE 4184–44–P
Number of
responses per
respondent
(total over
request
period)
588
554
Food and Drug Administration
[Docket Nos. FDA–2010–N–0190; FDA–
2012–N–0197; FDA–2014–N–1414; and
FDA–2014–N–0913]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals
Food and Drug Administration,
HHS.
VerDate Sep<11>2014
17:05 Aug 09, 2021
Jkt 253001
1
1
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
Total burden
(in hours)
.5
.5
ACTION:
Annual burden
(in hours)
294
277
294
277
Notice.
The Food and Drug
Administration (FDA) is publishing a
list of information collections that have
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
SUMMARY:
Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\10AUN1.SGM
10AUN1
43666
Federal Register / Vol. 86, No. 151 / Tuesday, August 10, 2021 / Notices
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
The
following is a list of FDA information
collections recently approved by OMB
under section 3507 of the Paperwork
SUPPLEMENTARY INFORMATION:
Reduction Act of 1995 (44 U.S.C. 3507).
The OMB control number and
expiration date of OMB approval for
each information collection are shown
in table 1. Copies of the supporting
statements for the information
collections are available on the internet
at https://www.reginfo.gov/public/do/
PRAMain. An Agency may not conduct
or sponsor, and a person is not required
to respond to, a collection of
information unless it displays a
currently valid OMB control number.
TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB
OMB control
number
Title of collection
Infant Formula Requirements ..................................................................................................................................
Shortages Data Collection .......................................................................................................................................
Guidance on Labeling for Natural Rubber Latex Condoms ....................................................................................
Section 513(g) Requests for Information ................................................................................................................
Dated: August 5, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2021–17045 Filed 8–9–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–N–1648]
Pediatric Advisory Committee; Notice
of Meeting; Establishment of a Public
Docket; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of a
public docket; request for comments.
ACTION:
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the Pediatric Advisory
Committee. The general function of the
committee is to provide advice and
recommendations to FDA on regulatory
issues. The meeting will be open to the
public. FDA is establishing a docket for
public comment on this document.
DATES: The meeting will be held on
September 17, 2021, from 10 a.m. to
4:30 p.m. Eastern Time.
ADDRESSES: Please note that due to the
impact of the COVID–19 pandemic, all
meeting participants will be joining this
advisory committee meeting via an
online teleconferencing platform.
Answers to commonly asked questions
including information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm408555.htm.
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:05 Aug 09, 2021
Jkt 253001
FDA is establishing a docket for
public comment on this meeting. The
docket number is FDA–2020–N–1648.
The docket will close on September 16,
2021. Submit either electronic or
written comments on this public
meeting by September 16, 2021. Please
note that late, untimely filed comments
will not be considered. Electronic
comments must be submitted on or
before September 16, 2021. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
September 16, 2021. Comments received
by mail/hand delivery/courier (for
written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
Comments received on or before
September 3, 2021, will be provided to
the committee. Comments received after
that date will be taken into
consideration by FDA. In the event that
the meeting is cancelled, FDA will
continue to evaluate any relevant
applications or information, and
consider any comments submitted to the
docket, as appropriate.
You may submit comments as
follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
0910–0256
0910–0491
0910–0633
0910–0705
Date approval
expires
5/31/2024
6/30/2024
6/30/2024
6/30/2024
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2020–N–1648 for ‘‘Pediatric Advisory
Committee; Notice of Meeting;
Establishment of a Public Docket;
Request for Comments.’’ Received
comments, those filed in a timely
manner (see ADDRESSES), will be placed
in the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 86, Number 151 (Tuesday, August 10, 2021)]
[Notices]
[Pages 43665-43666]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17045]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2010-N-0190; FDA-2012-N-0197; FDA-2014-N-1414; and
FDA-2014-N-0913]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD
[[Page 43666]]
20852, 301-796-7726, [email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection number expires
------------------------------------------------------------------------
Infant Formula Requirements............. 0910-0256 5/31/2024
Shortages Data Collection............... 0910-0491 6/30/2024
Guidance on Labeling for Natural Rubber 0910-0633 6/30/2024
Latex Condoms..........................
Section 513(g) Requests for Information. 0910-0705 6/30/2024
------------------------------------------------------------------------
Dated: August 5, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-17045 Filed 8-9-21; 8:45 am]
BILLING CODE 4164-01-P
